Cortlandt, Deborah

Cortlandt, Deborah was paid $25K by Medicaid between May 2019 and Dec 2019, across 5 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 62% of everything it billed.

33Billing provider infoCORTLANDT, DEBORAH
WINNFIELD, LA 71483

33aNPI1669479317assigned 07/07/2005

33bProvider typeCardiovascular Disease Physician

28Total paid$25K

24GClaims780

24DCodes billed5

24AFirst – last monthMay 2019 – Dec 2019

Compared with peers

Next to other Cardiovascular Disease Physician providers in Louisiana

Rank by total paid#41 of 72

Median peer was paid$51K

This provider vs. median0.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	780	$25K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	62%	445	282	$16K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	28%	187	128	$7K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	7.5%	76	66	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.6%	20	14	$409.31
81025		1.3%	52	52	$326.32

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.